The topology of hepatitis B virus pregenomic RNA promotes its replication.
Previous analysis of hepatitis B virus (HBV) indicated base pairing between two cis-acting sequences, the 5' half of the upper stem of epsilon and phi, contributes to the synthesis of minus-strand DNA. Our goal was to identify other cis-acting sequences on the pregenomic RNA (pgRNA) involved in the synthesis of minus-strand DNA. We found that large portions of the pgRNA could be deleted or substituted without an appreciable decrease in the level of minus-strand DNA synthesized, indicating that most of the pgRNA is dispensable and that a specific size of the pgRNA is not required for this process. Our results indicated that the cis-acting sequences for the synthesis of minus-strand DNA are present near the 5' and 3' ends of the pgRNA. In addition, we found that the first-strand template switch could be directed to a new location when a 72-nucleotide (nt) fragment, which contained the cis-acting sequences present near the 3' end of the pgRNA, was introduced at that location. Within this 72-nt region, we uncovered two new cis-acting sequences, which flank the acceptor site. We show that one of these sequences, named omega and located 3' of the acceptor site, base pairs with phi to contribute to the synthesis of minus-strand DNA. Thus, base pairing between three cis-acting elements (5' half of the upper stem of epsilon, phi, and omega) are necessary for the synthesis of HBV minus-strand DNA. We propose that this topology of pgRNA facilitates first-strand template switch and/or the initiation of synthesis of minus-strand DNA.
Abraham
Teresa M
TM
McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Loeb
Daniel D
DD
D001483:Base Sequence; D045744:Cell Line, Tumor; D003001:Cloning, Molecular; D003593:Cytoplasm / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D004279:DNA, Viral / Q000235:genetics; D017353:Gene Deletion; D016679:Genome, Viral; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D008957:Models, Genetic; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D012367:RNA, Viral / Q000235:genetics*; D014779:Virus Replication
D017931:DNA Primers; D004279:DNA, Viral; D012367:RNA, Viral
Virology. 2002 Apr 10;295(2):348-59
12033794
Virology. 2007 Mar 15;359(2):371-81
17056086
J Virol. 2004 Jan;78(2):642-9
14694095
Cell. 1980 Oct;21(3):801-9
7438207
Cell. 1982 Jun;29(2):403-15
6180831
Cell. 1986 Sep 12;46(6):865-72
3019554
Nature. 1990 Apr 5;344(6266):552-5
1690862
EMBO J. 1992 Sep;11(9):3413-20
1380455
Cell. 1992 Nov 13;71(4):663-70
1384989
J Virol. 1993 Jun;67(6):3254-63
7684464
J Virol. 1993 Nov;67(11):6507-12
7692081
J Virol. 1994 Jan;68(1):6-13
7504742
J Virol. 1994 Jun;68(6):3536-43
8189492
J Virol. 1994 Sep;68(9):5579-87
7520092
J Virol. 1995 May;69(5):3067-73
7707534
J Virol. 1996 Jan;70(1):585-9
8523575
J Virol. 1996 May;70(5):2764-73
8627750
Virology. 1997 Nov 24;238(2):363-71
9400609
Mol Cell Biol. 1998 Nov;18(11):6265-72
9774643
J Virol. 2006 May;80(9):4380-7
16611897
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1984-9
12578983